Kathy H. C. Wu

1.0k total citations
23 papers, 309 citations indexed

About

Kathy H. C. Wu is a scholar working on Molecular Biology, Genetics and Ophthalmology. According to data from OpenAlex, Kathy H. C. Wu has authored 23 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Ophthalmology. Recurrent topics in Kathy H. C. Wu's work include Retinal Diseases and Treatments (7 papers), Genomics and Rare Diseases (6 papers) and Pancreatic function and diabetes (4 papers). Kathy H. C. Wu is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Genomics and Rare Diseases (6 papers) and Pancreatic function and diabetes (4 papers). Kathy H. C. Wu collaborates with scholars based in Australia, United States and United Kingdom. Kathy H. C. Wu's co-authors include Paul Mitchell, Jie Jin Wang, Margaret A. Vizzard, Elena Rochtchina, Ava Grace Tan, Andrew J Williams, Emmanuel J. Favaloro, Michael F. Marmor, Mark S. Blumenkranz and Douglas Vollrath and has published in prestigious journals such as SHILAP Revista de lepidopterología, Anesthesiology and American Journal of Ophthalmology.

In The Last Decade

Kathy H. C. Wu

18 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy H. C. Wu Australia 7 168 132 82 36 26 23 309
Cristina Llombart Spain 8 192 1.1× 169 1.3× 106 1.3× 20 0.6× 78 3.0× 10 390
Zala Lužnik Slovenia 11 98 0.6× 45 0.3× 153 1.9× 29 0.8× 20 0.8× 23 325
Shi Ma China 14 129 0.8× 235 1.8× 108 1.3× 21 0.6× 54 2.1× 31 429
Philippe Lapalus France 12 220 1.3× 150 1.1× 192 2.3× 43 1.2× 20 0.8× 19 426
Kimberly A. Toops United States 13 242 1.4× 302 2.3× 73 0.9× 48 1.3× 39 1.5× 18 500
L Franse-Carman United States 6 279 1.7× 148 1.1× 96 1.2× 22 0.6× 47 1.8× 6 390
Joanna Wisniewska‐Kruk Netherlands 5 75 0.4× 135 1.0× 32 0.4× 34 0.9× 58 2.2× 8 220
Roselie M.H. Diederen Netherlands 14 401 2.4× 145 1.1× 304 3.7× 21 0.6× 11 0.4× 41 540
Senthil Selvam India 4 250 1.5× 125 0.9× 208 2.5× 25 0.7× 31 1.2× 6 390
Kaoru Tsujikawa Japan 11 138 0.8× 151 1.1× 157 1.9× 14 0.4× 23 0.9× 15 352

Countries citing papers authored by Kathy H. C. Wu

Since Specialization
Citations

This map shows the geographic impact of Kathy H. C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy H. C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy H. C. Wu more than expected).

Fields of papers citing papers by Kathy H. C. Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy H. C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy H. C. Wu. The network helps show where Kathy H. C. Wu may publish in the future.

Co-authorship network of co-authors of Kathy H. C. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy H. C. Wu. A scholar is included among the top collaborators of Kathy H. C. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy H. C. Wu. Kathy H. C. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devery, Sophie, et al.. (2025). Endocrinologist-led genomic testing for monogenic diabetes in adult diabetes clinics: a feasibility and outcome study. Diabetes Research and Clinical Practice. 229. 112456–112456.
2.
Sousa, Sunita M C De, et al.. (2025). Improving detection of monogenic diabetes through reanalysis of GCK variants of uncertain significance. Acta Diabetologica. 62(8). 1283–1289. 2 indexed citations
3.
Rafehi, Haloom, Liam G. Fearnley, Penny Snell, et al.. (2025). Comprehensive Characterisation of the RFC1 Repeat in an Australian Cohort. The Cerebellum. 24(4). 111–111.
4.
Sousa, Sunita M C De, Timothy M. E. Davis, James Harraway, et al.. (2025). Australian and New Zealand joint society consensus statement on genetic testing for monogenic diabetes in adults. The Medical Journal of Australia. 223(9). 484–491. 2 indexed citations
5.
6.
Tchan, Michel, Sophie Devery, Rupendra Shrestha, et al.. (2023). Informing a value care model: lessons from an integrated adult neurogenomics clinic. Internal Medicine Journal. 53(12). 2198–2207. 3 indexed citations
7.
Wu, Kathy H. C., et al.. (2023). A mitochondrial cytopathy presenting with persistent troponin elevation: case report. European Heart Journal - Case Reports. 7(4). ytad132–ytad132.
8.
Sousa, Sunita M C De, Kathy H. C. Wu, Kevin Colclough, et al.. (2023). Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing. Acta Diabetologica. 61(2). 181–188. 4 indexed citations
9.
Tisch, Stephen, Michel Tchan, Victor S.C. Fung, et al.. (2022). A novel synonymous KMT2B variant in a patient with dystonia causes aberrant splicing. Molecular Genetics & Genomic Medicine. 10(5). e1923–e1923. 4 indexed citations
10.
Tchan, Michel, et al.. (2021). 087 An integrated neurogenomics clinic – 28-months experience and outcome of a tertiary referral centre. SHILAP Revista de lepidopterología. A32.1–A32.
11.
Hussain, Iram, Howard B. A. Baum, Jerry R. Greenfield, et al.. (2020). Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an LMNA p.R349W Variant. Journal of the Endocrine Society. 4(10). bvaa104–bvaa104. 10 indexed citations
12.
Libianto, Renata, Kathy H. C. Wu, Sophie Devery, & John A. Eisman. (2019). KBG syndrome presenting with brachydactyly type E. Bone. 123. 18–22. 5 indexed citations
13.
Chan, Annie, Mark S. Blumenkranz, Kathy H. C. Wu, et al.. (2009). Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide: A Retrospective Comparative Study. Ophthalmic surgery, lasers & imaging retina. 40(6). 561–569. 4 indexed citations
14.
Blumenkranz, Mark S., et al.. (2006). A Novel His158Arg Mutation in TIMP3 Causes a Late-Onset Form of Sorsby Fundus Dystrophy. American Journal of Ophthalmology. 142(5). 839–848.e3. 27 indexed citations
15.
Wu, Kathy H. C. & Michael F. Marmor. (2005). Alcohol- and Light-induced Electro-oculographic Responses in Age-related Macular Degeneration & Central Serous Chorioretinopathy. Documenta Ophthalmologica. 110(2-3). 237–246. 4 indexed citations
16.
Marmor, Michael F. & Kathy H. C. Wu. (2005). Alcohol- and Light-induced Electro-oculographic Responses: Variability and Clinical Utility. Documenta Ophthalmologica. 110(2-3). 227–236. 6 indexed citations
17.
Wu, Kathy H. C., Jie Jin Wang, Elena Rochtchina, et al.. (2004). Angiotensin‐converting enzyme inhibitors (ACEIs) and age‐related maculopathy (ARM): cross‐sectional findings from the Blue Mountains Eye Study. Acta Ophthalmologica Scandinavica. 82(3p1). 298–303. 5 indexed citations
18.
Wu, Kathy H. C.. (2003). Differential expression of GFAP in early v late AMD: a quantitative analysis. British Journal of Ophthalmology. 87(9). 1159–1166. 125 indexed citations
19.
Wu, Kathy H. C., Philip L. Penfold, & Francis A. Billson. (2002). Effects of post‐mortem delay and storage duration on the expression of GFAP in normal human adult retinae. Clinical and Experimental Ophthalmology. 30(3). 200–207. 10 indexed citations
20.
Vizzard, Margaret A., et al.. (2000). Developmental expression of urinary bladder neurotrophic factor mRNA and protein in the neonatal rat. Developmental Brain Research. 119(2). 217–224. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Llombart Breakdown of academic impact, for papers by Zala Lužnik Breakdown of academic impact, for papers by Shi Ma Breakdown of academic impact, for papers by Philippe Lapalus Breakdown of academic impact, for papers by Kimberly A. Toops Breakdown of academic impact, for papers by L Franse-Carman Breakdown of academic impact, for papers by Joanna Wisniewska‐Kruk Breakdown of academic impact, for papers by Roselie M.H. Diederen Breakdown of academic impact, for papers by Senthil Selvam Breakdown of academic impact, for papers by Kaoru Tsujikawa
Rankless by CCL
2026